---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-002613"
form_type: "8-K"
ticker: "DWTX"
cik: "0001818844"
company_name: "Dogwood Therapeutics, Inc."
filed_at: "2024-03-06T23:59:59+00:00"
generated_at: "2026-06-05T02:51:28.009176+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Virios shareholders approve reverse stock split at special meeting

## Summary
- Special meeting held March 1, 2024; quorum 64.58% of shares outstanding.
- Proposal 1 (reverse stock split) approved with 7,553,703 For vs 4,697,955 Against.
- Proposal 2 (adjournment to solicit proxies) approved with 7,778,383 For vs 4,484,974 Against.
- No broker non-votes; both proposals passed by required vote.
- Reverse split effective date and ratio not disclosed in this filing.

## SEC filing metadata
- accession: 0001558370-24-002613
- form_type: 8-K
- ticker: DWTX
- cik: 0001818844
- company_name: Dogwood Therapeutics, Inc.
- filed_at: 2024-03-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818844/000155837024002613/0001558370-24-002613-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818844/000155837024002613/tmb-20240301x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-002613
- JSON: https://secwatch.observer/filing/0001558370-24-002613.json
- Plain text: https://secwatch.observer/filing/0001558370-24-002613.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.